- Home
- QTTB vs JYD Comparison
QTTB vs JYD Comparison
Compare QTTB & JYD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- QTTB
- JYD
- Stock Information
- Founded
- QTTB 2015
- JYD 2001
- Country
- QTTB United States
- JYD China
- Employees
- QTTB N/A
- JYD N/A
- Industry
- QTTB Biotechnology: Pharmaceutical Preparations
- JYD Oil Refining/Marketing
- Sector
- QTTB Health Care
- JYD Consumer Discretionary
- Exchange
- QTTB Nasdaq
- JYD Nasdaq
- Market Cap
- QTTB 23.3M
- JYD 18.9M
- IPO Year
- QTTB N/A
- JYD 2023
- Fundamental
- Price
- QTTB $2.27
- JYD $3.75
- Analyst Decision
- QTTB Hold
- JYD
- Analyst Count
- QTTB 7
- JYD 0
- Target Price
- QTTB $12.17
- JYD N/A
- AVG Volume (30 Days)
- QTTB 214.3K
- JYD 110.7K
- Earning Date
- QTTB 11-07-2025
- JYD 12-04-2025
- Dividend Yield
- QTTB N/A
- JYD N/A
- EPS Growth
- QTTB N/A
- JYD N/A
- EPS
- QTTB N/A
- JYD N/A
- Revenue
- QTTB N/A
- JYD $80,305,742.00
- Revenue This Year
- QTTB N/A
- JYD N/A
- Revenue Next Year
- QTTB N/A
- JYD N/A
- P/E Ratio
- QTTB N/A
- JYD N/A
- Revenue Growth
- QTTB N/A
- JYD N/A
- 52 Week Low
- QTTB $1.35
- JYD $3.61
- 52 Week High
- QTTB $51.26
- JYD $400.00
- Technical
- Relative Strength Index (RSI)
- QTTB 40.57
- JYD 51.27
- Support Level
- QTTB $2.50
- JYD $3.80
- Resistance Level
- QTTB $2.61
- JYD $4.71
- Average True Range (ATR)
- QTTB 0.31
- JYD 0.42
- MACD
- QTTB -0.12
- JYD -0.29
- Stochastic Oscillator
- QTTB 8.28
- JYD 6.49
About QTTB Q32 Bio Inc. Common Stock
Q32 Bio Inc is a clinical-stage biotechnology company focused on developing novel biologics to effectively and safely restore healthy immune balance in patients with autoimmune & inflammatory diseases driven by pathological immune dysfunction. Q32 is advancing antibody-based therapeutic candidates designed to target two central pathways of adaptive & innate immunity. The adaptive immune system is largely composed of T- & B-cell mediated cellular & antibody responses, while the innate immune system is the body's first line of defense employing leukocytes that are responsible for clearing pathogens and cellular debris and modulating T- & B-cell function. ADX-097, the lead product candidate from Q32's complement inhibitor platform, is a humanized anti-C3d monoclonal antibody fusion protein.
About JYD Jayud Global Logistics Limited
Jayud Global Logistics Ltd is an end-to-end supply chain solution provider in China, with a focus on providing cross-border logistics services. The company offers freight forwarding services, supply chain management, and other value-added services.